Survival Improved With Everolimus in High-Risk Clear Cell Renal Cancer

MONDAY, Oct. 23, 2023 -- For patients with clear cell renal cell carcinoma (RCC) at very high risk for recurrence, adjuvant everolimus is associated with significantly improved recurrence-free survival, according to a study presented at the annual...